Home/Filings/4/0001127602-22-005065
4//SEC Filing

Patterson Robert M 4

Accession 0001127602-22-005065

CIK 0001122976other

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 5:20 PM ET

Size

13.0 KB

Accession

0001127602-22-005065

Insider Transaction Report

Form 4
Period: 2022-02-11
Patterson Robert M
SVP & Chief Financial Officer
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2022-02-1148,95048,950 total
    From: 2022-02-11Exp: 2022-02-11Common Stock (48,950 underlying)
  • Exercise/Conversion

    Common Stock

    2022-02-11+48,950548,361 total
  • Tax Payment

    Common Stock

    2022-02-11$52.64/sh23,297$1,226,354525,064 total
  • Award

    Restricted Stock Units

    2022-02-14+38,15038,150 total
    From: 2025-02-14Exp: 2025-02-14Common Stock (38,150 underlying)
  • Award

    Stock Appreciation Rights

    2022-02-14+134,700134,700 total
    Exercise: $52.64Exp: 2032-02-14Common Stock (134,700 underlying)
Footnotes (4)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Avient common stock.
  • [F2]Includes dividend equivalents earned with respect to the vested restricted stock units.
  • [F3]Represents shares of Avient common stock that were withheld solely to satisfy the tax withholding obligation applicable to the vesting of restricted stock units on February 11, 2022.
  • [F4]SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $52.64 per share and no more than one-third of the grant can vest per year during the first three years.

Issuer

AVIENT CORP

CIK 0001122976

Entity typeother

Related Parties

1
  • filerCIK 0001433828

Filing Metadata

Form type
4
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 5:20 PM ET
Size
13.0 KB